Article Date: 26 Feb 2011 – 0:00 PST
A rare genetic malfunction which only affects 0.3% of patients may eventually lead the way to better treatment for some individuals with schizophrenia, say scientists from the University of California, San Diego, USA. The NIH-funded study found that people with schizophrenia are 14 times more likely to have multiple copies of a gene on Chromosome 7 than those in the control group.
The faults were found in the gene for VIPR2, the receptor for VIP (vasoactive intestinal peptide). VIP is a chemical messenger experts say plays a role in the development of the brain. When examining patients’ blood they found that they had excess VIP activity.
Read in Full:
http://www.medicalnewstoday.com/articles/217530.php
Leave a Reply